Methamphetamine has been placed in schedule II of the United Nations Convention on Psychotropic Substances treaty. Research
It has been suggested, based on animal research, that calcitriol, the active metabolite of vitamin D, can provide significant protection against the DA- and 5-HT-depleting effects of neurotoxic doses of methamphetamine. See also
18-MC
Breaking Bad, a TV drama series centered on illicit methamphetamine synthesis
Drug checking
Faces of Meth, a drug prevention project
Harm reduction
Methamphetamine in Australia
Methamphetamine in Bangladesh
Methamphetamine in the Philippines
Methamphetamine in the United States
Montana Meth Project, a Montana-based organization aiming to reduce meth use among teenagers
Recreational drug use
Rolling meth lab, a transportable laboratory that is used to illegally produce methamphetamine
Ya ba, Southeast Asian tablets containing a mixture of methamphetamine and caffeine

Explanatory notes
Image legend

Reference notes
References
Further reading
Szalavitz M. "Why the Myth of the Meth-Damaged Brain May Hinder Recovery". Time.com. Time USA, LLC. Hart CL, Marvin CB, Silver R, Smith EE (February 2012). "Is cognitive functioning impaired in methamphetamine users? A critical review". Neuropsychopharmacology. 37 (3): 586–608. doi:10.1038/npp.2011.276. ISSN 0893-133X. PMC 3260986. PMID 22089317. Maia Szalavitz (21 November 2011). "Why the Myth of the Meth-Damaged Brain May Hinder Recovery". Time. External links

Methamphetamine Toxnet entry
Methamphetamine Poison Information Monograph
Drug Trafficking: Aryan Brotherhood Methamphetamine Operation Dismantled, FBI
Neurologic manifestations of chronic methamphetamine abuse
In the brain, the dorsal striatum may be associated with physical (motor) but not affective withdrawal sign. Treatment
Gradually reducing nicotine intake causes less withdrawal than abruptly stopping. Another way to reduce nicotine withdrawal symptoms is to provide the body with an alternative source of nicotine (nicotine replacement therapy) for a temporary period and then taper this new nicotine intake. Other medication used for quitting smoking include bupropion, varenicline, cytisine, nortriptyline, and clonidine. Treatments other than medication, such as increased exercise, can also reduce nicotine withdrawal. Many behavior changes such as avoiding situations where one usually smoked, planning ahead to deal with temptations, and seeking the support of friends and family are effective in helping people quit smoking, but whether this is due to reduced withdrawal is unclear. Epidemiology
Most nicotine users have at least one of the above withdrawal symptoms when they try to stop. These effects are much milder to those who use isolated nicotine over tobacco. Withdrawal can occur in less frequent  users, but heavier users and those with a past or current psychiatric disorder tend to have more severe withdrawal. Genetics also influence the severity of withdrawal. See also
Withdrawal
Smoking cessation
Nicotine dependence

References


== External links ==